The European Medicines Agency’s (EMA) pharmacovigilance committee (PRAC) has completed its review of a safety signal of ...
Following a review, the European Medicines Agency (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) has recommended that modified- or prolonged-release paracetamol (acetaminophen) be removed ...
The European Medicine Agency's (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) has recommended restricting the use of systemic and inhaled fluoroquinolone and quinolone antibiotics following ...
The Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA) has issued its recommendation to revoke the marketing authorization of 5-mg ulipristal acetate (Esmya and ...
Topiramate can cause serious birth defects if exposed to children in the womb. In a European Medicines Agency (EMA) press release on September 9, 2023, the agency’s Pharmacovigilance Risk Assessment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results